Logo

American Heart Association

  19
  0


Final ID: MP1712

Interaction of Age, Peripheral Artery Disease, and In-hospital Outcomes Among Patients Undergoing Index Percutaneous Interventions

Abstract Body (Do not enter title and authors here): Introduction: Peripheral artery disease (PAD) is known risk factor for adverse cardiovascular outcomes as well as coronary artery disease. However, the interaction between PAD and advanced age on outcomes after percutaneous coronary intervention (PCI) remains understudied and may aid in risk stratification. We aimed to assess the association of PAD with in-hospital mortality and length of stay (LOS) in patients undergoing PCI, and to evaluate the interaction between PAD and age in each model.
Methods: We included patients ≥18 years old from the Vizient® Clinical Data Base from 2016–2023 undergoing an index PCI. PAD was defined using ICD-10 codes. Age ≥80 years was used to define the older age stratum for interaction analysis. Multivariable logistic regression analysis and Poisson regression models were used to assess the association between PAD and in-hospital mortality and LOS, respectively, adjusting for demographics, hospital characteristics, and clinical comorbidities. Predicted LOS and mortality risk were calculated as well as interaction terms between PAD and age ≥80 for each model.
Results: We included 287,150 patients (mean age 79.8 years ± 14.8; female 31.7%, 13.8% had PAD). PAD was significantly associated with in-hospital mortality (OR=1.25; 95% CI 1.15–1.35; p<0.001). The interaction between PAD and age ≥80 for in-hospital mortality was significant (p=0.001). Compared with patients <80 years old without PAD, in-hospital mortality was increasingly associated among patients ≥80 years old without PAD (OR 1.65; 95% CI 1.60–1.71; p<0.001), higher among patients <80 years old with PAD (OR 1.50; 95% CI 1.31–1.72; p<0.001), and strongest among patients ≥80 years old with PAD (OR 1.77; 95% CI 1.61–1.95; p<0.001). PAD was also associated with a significantly longer LOS (IRR = 1.13; 95% CI 1.12–1.14; p<0.001), with a significant interaction with age (p=0.001). Compared with patients <80 without PAD, LOS was higher in those age ≥80 without PAD (IRR = 1.088; 95% CI 1.084–1.092), and significantly higher in those with PAD across the age spectrum (<80: IRR = 1.192; 95% CI 1.175–1.210; p<0.001; ≥80: IRR = 1.194; 95% CI 1.182–1.208; p<0.001).
Conclusion: PAD is associated with a prolonged LOS and higher in-hospital mortality in those undergoing PCI. There is a significant interaction between PAD and age ≥80 years for both LOS and in-hospital mortality, suggesting older adults are a vulnerable sub-group for prolonged care and fatality following a PCI trajectory.
  • Callegari, Santiago  ( Yale University , New Haven , Connecticut , United States )
  • Mena-hurtado, Carlos  ( Yale University , New Haven , Connecticut , United States )
  • Nanna, Michael  ( Yale University , New Haven , Connecticut , United States )
  • Akman, Zafer  ( Yale School of Medicine , New Haven , Connecticut , United States )
  • Rossi, Raiza  ( Yale University , New Haven , Connecticut , United States )
  • Rahman, Mufti  ( Yale University , New Haven , Connecticut , United States )
  • Cleman, Jacob  ( Yale University , New Haven , Connecticut , United States )
  • Garcia Castro, Gabriel  ( Yale University , New Haven , Connecticut , United States )
  • Nouri, Armin  ( Yale University , New Haven , Connecticut , United States )
  • Damluji, Abdulla  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Smolderen, Kim  ( Yale University , New Haven , Connecticut , United States )
  • Author Disclosures:
    Santiago Callegari: DO NOT have relevant financial relationships | Carlos Mena-Hurtado: DO have relevant financial relationships ; Consultant:Novonordisk:Active (exists now) ; Consultant:Terumo:Active (exists now) | Michael Nanna: DO have relevant financial relationships ; Consultant:HeartFlow, Inc.:Active (exists now) ; Consultant:Merck:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) | Zafer Akman: DO NOT have relevant financial relationships | Raiza Rossi: DO NOT have relevant financial relationships | Mufti Rahman: DO NOT have relevant financial relationships | Jacob Cleman: No Answer | Gabriel Garcia Castro: DO NOT have relevant financial relationships | Armin Nouri: No Answer | Abdulla Damluji: DO NOT have relevant financial relationships | Kim Smolderen: DO have relevant financial relationships ; Employee:Yale University:Active (exists now) ; Ownership Interest:BoboDream LLC:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Consultant:Merck:Active (exists now) ; Consultant:Terumo:Active (exists now) ; Consultant:Happify:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Best Clinical Epidemiology in Vascular Medicine

Sunday, 11/09/2025 , 09:15AM - 10:25AM

Moderated Digital Poster Session

More abstracts on this topic:
A Comparison of Outcomes in Heart Failure Patients with and without Iron Deficiency Anemia: A National Database Analysis

Bess Olva, Quevedo Ramirez Andres, Shaka Abdultawab, Oredipe Omotola, Bello Jeremiah, Shaka Hafeez

A Multi-centre, Randomized, Controlled Study of External CounterPulsation for Patients with Recent Atherosclerotic Stroke (SPA)

Xiong Li, Chen Xiangyan, Leung Howan, Zhu Lixia, Leung Thomas, Wong Lawrence

More abstracts from these authors:
Association Between Guideline-directed Medical Therapy and Reintervention Risk at 2 Years Following Peripheral Vascular Interventions

Callegari Santiago, Cleman Jacob, Rahman Mufti, Capuano Isabella, Smolderen Kim, Mena-hurtado Carlos, Romain Gaelle

Association Between Imaging Follow Up and 1-Year Reintervention Risk After Peripheral Vascular Intervention for Claudicatio

Romain Gaelle, Smolderen Kim, Cleman Jacob, Callegari Santiago, Rahman Mufti, Knight Derek, Mena-hurtado Carlos

You have to be authorized to contact abstract author. Please, Login
Not Available